Clinical trial
Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating…
NCT00053820 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00053820 |
|---|---|
| Title | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer |
| Official title | A Randomized Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs. Interferon-alpha Alone in Patients With Advanced Renal Cell Carcinoma |
| Lead sponsor | Medical Research Council, Other |
| Collaborators | European Organisation for Research and Treatment of Cancer - EORTC |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, recombinant interferon alfa, fluorouracil |
| Enrollment | 670 |
| Start date | Jul 1, 2002 |
| Completion | Dec 1, 2006 |
| First posted | Feb 6, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | Belgium, Germany, Netherlands, Slovakia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: